About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Study Points to New Therapies to Treat Life-Threatening Lung Condition

by Bidita Debnath on May 9, 2017 at 11:42 PM
Font : A-A+

 Study Points to New Therapies to Treat Life-Threatening Lung Condition

Researchers have pinpointed a chemical signal that worsens inflammation linked to a life-threatening lung condition.

The discovery could eventually lead to new therapies for the disease, which can be fatal for up to half of those affected.

Advertisement


Acute Respiratory Distress Syndrome (ARDS) is caused by widespread inflammation in the lungs and can lead to fluid leaking into the airways.

Researchers found that patients with ARDS had high levels of a type of molecule called mitochondrial formylated peptide in the fluid of their lungs.
Advertisement

Laboratory tests found that these molecules play a key role in attracting specialised immune cells called neutrophils. Neutrophils are known to be responsible for orchestrating the inflammation associated with ARDS.

Studies with mice found that blocking the molecules' signalling mechanisms helped to stem neutrophil infiltration and alleviate lung inflammation associated with ARDS.

Experts at the University of Edinburgh say the findings could pave the way for new therapies for the condition, which is untreatable.

ARDS typically affects patients who are already critically ill and can be triggered by severe injuries or infections such as pneumonia.

Mitochondrial formylated peptides are released from the body's cells when they die. Therapies that target these molecules could potentially help patients with any type of ARDS, whether caused by an infection or not, the researchers say.

The study is published in the journal Thorax. It was funded by the Wellcome Trust and the Medical Research Council.

Lead researcher Professor Adriano Rossi, of the University of Edinburgh's MRC Centre for Inflammation Research, said: "For the first time, we have demonstrated that these mitochondrial formylated peptides are present and elevated in ARDS and that they directly drive lung inflammation. This therefore highlights a potential novel therapeutic target for this life threatening illness."

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
World Disability Day 2022 - The Role of Innovative Transformation
Diet and Oral Health: The Sugary Connection May Become Sour
World AIDS Day 2022 - Equalize!
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Pneumoconiosis Silicosis Gastrointestinal bleeding (GI Bleed) 

Most Popular on Medindia

Sinopril (2mg) (Lacidipine) Find a Hospital Drug - Food Interactions Daily Calorie Requirements How to Reduce School Bag Weight - Simple Tips Noscaphene (Noscapine) Diaphragmatic Hernia Pregnancy Confirmation Calculator Selfie Addiction Calculator Accident and Trauma Care
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Study Points to New Therapies to Treat Life-Threatening Lung Condition Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests